Developing new drugs and vaccines to prevent cancer
TO Title: Contract Orientation & Kickoff Meeting for Preclinical Services for PREVENT Base IDIQ Title: PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate E
This study is working on developing new drugs and vaccines to help prevent cancer, and it's designed to benefit patients by finding safer and more effective ways to keep cancer at bay.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst of Fox Chase Can Ctr NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11020340 on NIH RePORTER |
What this research studies
This research focuses on the PREVENT Cancer Preclinical Drug Development Program, which aims to create a systematic process for developing new drugs and vaccines that can prevent cancer. The program involves various stages, from initial discovery to clinical application, ensuring that potential treatments are rigorously tested for efficacy and safety. Patients may benefit from advancements in cancer prevention strategies that arise from this comprehensive approach to drug and vaccine development.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for developing cancer or those interested in preventive measures against cancer.
Not a fit: Patients who are currently diagnosed with cancer or those who do not have a family history of cancer may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new preventive treatments that significantly reduce the incidence of cancer.
How similar studies have performed: Other research initiatives in cancer prevention have shown promise, indicating that structured drug and vaccine development can lead to successful outcomes.
Where this research is happening
Philadelphia, United States
- Research Inst of Fox Chase Can Ctr — Philadelphia, United States (Active)
Researchers
- Principal investigator: Clapper, Margie L. — Research Inst of Fox Chase Can Ctr
- Study coordinator: Clapper, Margie L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.